Interaction Among Noncoding RNAs, DNA Damage Reactions, and Genomic Instability in the Hypoxic Tumor: Is it

Suman Kumar Ray1, Sukhes Mukherjee2

  • 1Independent Researcher, India.

Insights

Tumor hypoxia, a hallmark of cancer, drives tumor progression and therapeutic resistance. Hypoxia-responsive non-coding RNAs (ncRNAs) significantly impact gene expression, DNA repair, and genomic instability in cancer cells, influencing outcomes.

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Background:

  • Tumor hypoxia is a critical factor influencing cancer development, progression, and treatment response.
  • Hypoxia activates signaling pathways controlling cell proliferation, angiogenesis, and survival, often exploited by cancer cells.
  • Hypoxia-inducible factor-1 alpha (HIF-1α) is a key regulator of gene expression in response to low oxygen environments.

Purpose of the Study:

  • To review the role of non-coding RNAs (ncRNAs) in tumor hypoxia.
  • To explore the involvement of ncRNAs in DNA damage responses and genomic instability within hypoxic tumors.
  • To highlight the clinical implications of ncRNAs in managing hypoxic cancers.

Main Methods:

  • Literature review and synthesis of current research on ncRNAs, hypoxia, and cancer.
  • Analysis of molecular mechanisms linking hypoxia, ncRNAs, and genomic alterations.
  • Discussion of emerging evidence on the clinical relevance of these interactions.

Main Results:

  • Hypoxia significantly alters gene expression, with ncRNAs playing crucial regulatory roles.
  • Hypoxia-responsive ncRNAs are increasingly recognized for their involvement in cancer progression.
  • Evidence suggests hypoxia-induced genetic instability is mediated, in part, by altered DNA repair pathways influenced by ncRNAs.

Conclusions:

  • ncRNAs are pivotal in mediating cancer cell adaptation and progression under hypoxic conditions.
  • Understanding the interplay between ncRNAs, hypoxia, DNA damage, and genomic instability is crucial for developing novel cancer therapies.
  • ncRNAs represent potential therapeutic targets and biomarkers for hypoxic tumors.

Related Concept Videos

Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
6.0K
Cancer Therapies02:49

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
8.0K
Regulation of Angiogenesis and Blood Supply01:24

Regulation of Angiogenesis and Blood Supply

Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits.  Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl...
2.8K
Nucleotide Excision Repair01:38

Nucleotide Excision Repair

DNA Distortion and Damage
Cells are regularly exposed to mutagens—factors in the environment that can damage DNA and generate mutations. UV radiation is one of the most common mutagens and is estimated to introduce a significant number of changes in DNA. These include bends or kinks in the structure, which can block DNA replication or transcription. If these errors are not fixed, the damage can cause mutations, which in turn can result in cancer or disease depending on which sequences are...
3.9K
Epigenetic Regulation01:37

Epigenetic Regulation

Epigenetic changes alter the physical structure of the DNA without changing the genetic sequence and often regulate whether genes are turned on or off. This regulation ensures that each cell produces only proteins necessary for its function. For example, proteins that promote bone growth are not produced in muscle cells. Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
X-chromosome...
3.2K
lncRNA - Long Non-coding RNAs02:39

lncRNA - Long Non-coding RNAs

In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...
9.0K